Prevalence of Acetylsalicylic Acid Use for Primary Prevention of Cardiovascular Disease Amongst Older Adults From 2017—2021: a Retrospective Cross-Sectional Study

BACKGROUND: Three landmark trials on the use of acetylsalicylic acid (ASA) for primary prevention of cardiovascular disease (CVD) were published in 2018. Since then, major clinical practice guidelines have been updated with recommendations against the routine use of ASA for primary CVD prevention, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolt, Jennifer, Barry, Arden R., Inglis, Colleen, Lin, Stephanie, Pan, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Canadian Geriatrics Society 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684304/
https://www.ncbi.nlm.nih.gov/pubmed/38045883
http://dx.doi.org/10.5770/cgj.26.693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684304/
https://www.ncbi.nlm.nih.gov/pubmed/38045883
http://dx.doi.org/10.5770/cgj.26.693

Ejemplares similares